Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weimer

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
AIDS (London, England)|January 11, 2000
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patientsR Bucciardini, A W Wu, M Floridia, et al.
Antiviral Therapy|October 11, 2012
No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravirSilvia Baroncelli, Ivano Mezzaroma, Alessandra Fantauzzi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) studyLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.
Therapeutic Drug Monitoring|September 25, 2013
Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimensSilvia Baroncelli, Paola Villani, Clementina M Galluzzo, et al.
The Journal of Infectious Diseases|February 1, 1997
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infectionM Floridia, S Vella, A C Seeber, et al.
International Journal of STD & AIDS|July 31, 2012
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsR Bucciardini, G D'Ettorre, S Baroncelli, et al.
Circulation|February 25, 2009
Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heartSihem Boudina, Heiko Bugger, Sandra Sena, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 3, 1999
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced diseaseM Floridia, R Bucciardini, D Ricciardulli, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
AIDS (London, England)|January 11, 2000
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patientsR Bucciardini, A W Wu, M Floridia, et al.
Antiviral Therapy|October 11, 2012
No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravirSilvia Baroncelli, Ivano Mezzaroma, Alessandra Fantauzzi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) studyLucia Palmisano, Marina Giuliano, Raffaella Bucciardini, et al.
Therapeutic Drug Monitoring|September 25, 2013
Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimensSilvia Baroncelli, Paola Villani, Clementina M Galluzzo, et al.
The Journal of Infectious Diseases|February 1, 1997
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infectionM Floridia, S Vella, A C Seeber, et al.
International Journal of STD & AIDS|July 31, 2012
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsR Bucciardini, G D'Ettorre, S Baroncelli, et al.
Circulation|February 25, 2009
Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heartSihem Boudina, Heiko Bugger, Sandra Sena, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 3, 1999
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced diseaseM Floridia, R Bucciardini, D Ricciardulli, et al.
Pageof 5